animenews: Sarepta shares sink as FDA staff stay sour on muscle disorder drug

Affichage des articles dont le libellé est Sarepta shares sink as FDA staff stay sour on muscle disorder drug. Afficher tous les articles

jeudi 21 avril 2016

Sarepta shares sink as FDA staff stay sour on muscle disorder drug

(Reuters) - Sarepta Therapeutics Inc lost more than a third of its market value after U.S. Food and Administration staff maintained their negative outlook on the company's rare muscle wasting disorder drug on Thursday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro

animenews

تعديل

jeudi 21 avril 2016

Sarepta shares sink as FDA staff stay sour on muscle disorder drug

التسميات

أرشيف المدونة الإلكترونية